AstraZeneca Trials Show Antibody Drug More Than 80% Effective At Preventing COVID-19

AstraZeneca is a drugmaker that is making the vaccine for the coronavirus too. They have stated that the drug is great, and it is supposed to be successfully preventing the Covid 19 Infection in people by 80%. So the effectiveness of the drug is high as in the percentage. We are happy to share this news with you guys. However, this is not completely determined yet, and there is a lot to be done still now.

The company had been working on this for quite some time, and they said this in a statement that according to the new data that they are getting from the AZD7442 COVID-19 Provent prevention and Tackle outpatient treatment Currently going on in Phase III trials are going on really well, and they have shown “robust efficacy” from a one-time intramuscular dose which had been given of the long-acting antibody (LAAB) combination.

AstraZeneca Trials Show Antibody Drug More Than 80% Effective At Preventing COVID-19

“The AZD7442 PROVENT trial is the first Phase III trial prospectively designed to evaluate a monoclonal antibody for pre-exposure prophylaxis of symptomatic COVID-19, with targeted inclusion of high-risk and immunocompromised participants. More than 75% of PROVENT participants at baseline had co-morbidities that put them at high risk for severe COVID-19 if they were to become infected, including people who are immunocompromised and may have a reduced immune response to vaccination,” AstraZeneca wrote in a statement to the public.

The fun fact is there is no death or any serious cases of the Covid 19 Infection that we can find in the people who have taken this antibody-drug. This is, therefore, very promising. We are sure that this will be something in the future. We just wanted to let you know about it so that you are well informed about the Covid 19 Infection treatment scene going on around you.

That is all for now. We hope that you take care of yourself and your family.